Spyre Therapeutics, Inc. (SYRE) research: valuation against peers, fundamentals over time, risk and news coverage
SYRE
Spyre Therapeutics, Inc.No data in this window.
Every report in our own archive tagged with this symbol, newest first — fetched from the archive alongside the market data.
- SPECIAL REPORTBEARISHInsider Selling Wave Sweeps US Mid-Caps as Executives Trim Into Strength
A dense batch of Form 4 disclosures over the past 24 hours points to broad-based insider distribution across financials, gaming, healthcare and industrials — a classic late-cycle signature that institutional desks watch for confirmation of stretched valuations.
Every figure on this page is fetched and computed in your browser from free public sources — end-of-day prices and reported financials from Yahoo Finance's open endpoints, and our own archive for the coverage panel. Fundamental history on the free tier runs about four fiscal years and five quarters. Data is best-effort and unaudited; this is market research, not investment advice.